Description

SANTIA MET 100 MG (1X7)

Indications

SANTIA MET 100 MG is primarily indicated for the management of type 2 diabetes mellitus in adults. It is often prescribed as part of a comprehensive treatment plan that includes diet, exercise, and weight control. This medication is particularly beneficial for patients who have not achieved adequate glycemic control with diet and exercise alone. SANTIA MET may be used alone or in combination with other antidiabetic agents.

Mechanism of Action

The active ingredients in SANTIA MET work synergistically to improve glycemic control. The formulation typically contains Metformin, which primarily works by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and enhancing insulin sensitivity in peripheral tissues. This multifaceted approach helps to lower blood sugar levels effectively.

Pharmacological Properties

Metformin, the main component of SANTIA MET, is classified as a biguanide. It is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 2-3 hours after oral administration. The drug is not metabolized by the liver and is excreted unchanged in the urine. The half-life of Metformin is approximately 6 hours, which allows for once or twice daily dosing in most patients.

Contraindications

SANTIA MET is contraindicated in patients with known hypersensitivity to Metformin or any of the excipients in the formulation. It should not be used in individuals with renal impairment (eGFR < 30 mL/min), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in patients with severe liver dysfunction. Additionally, caution should be exercised in patients with a history of lactic acidosis.

Side Effects

Common side effects associated with SANTIA MET include gastrointestinal disturbances such as nausea, vomiting, diarrhea, abdominal discomfort, and flatulence. These symptoms are often transient and may improve with continued use. Rare but serious side effects include lactic acidosis, particularly in patients with renal impairment or other risk factors. Patients should be monitored for signs of lactic acidosis, such as muscle pain, difficulty breathing, and abdominal discomfort.

Dosage and Administration

The recommended starting dose of SANTIA MET is typically 500 mg once or twice daily, taken with meals to minimize gastrointestinal side effects. The dose may be gradually increased based on the patient’s blood glucose levels and tolerance, with a maximum recommended dose of 2000-2500 mg per day depending on the specific formulation. It is essential to adhere to the prescribed dosage and to consult a healthcare provider before making any changes to the medication regimen.

Interactions

SANTIA MET may interact with various medications, which can affect its efficacy and safety profile. Concomitant use of diuretics, corticosteroids, and other medications that may affect renal function should be approached with caution. Additionally, the use of alcohol can increase the risk of lactic acidosis. It is crucial for patients to inform their healthcare providers about all medications they are taking, including over-the-counter drugs and supplements, to avoid potential interactions.

Precautions

Patients using SANTIA MET should be regularly monitored for renal function, particularly in older adults or those with existing renal impairment. It is also essential to assess liver function periodically, as hepatic dysfunction can increase the risk of lactic acidosis. Patients should be educated about the signs and symptoms of lactic acidosis and advised to seek immediate medical attention if they experience any concerning symptoms. Furthermore, SANTIA MET should be temporarily discontinued in situations that may lead to renal impairment, such as dehydration, surgery, or severe infection.

Clinical Studies

Clinical studies have demonstrated the efficacy of Metformin in lowering blood glucose levels and reducing the risk of diabetes-related complications. In a study published in the Journal of Clinical Endocrinology & Metabolism, Metformin was shown to significantly improve glycemic control in patients with type 2 diabetes when compared to placebo. Additionally, long-term studies have indicated that Metformin may have cardiovascular benefits, reducing the risk of heart disease in diabetic patients. These findings support the use of SANTIA MET as a first-line treatment option for managing type 2 diabetes.

Conclusion

SANTIA MET 100 MG is an effective therapeutic option for managing type 2 diabetes mellitus. Its dual mechanism of action, along with its favorable safety profile, makes it a suitable choice for many patients. However, it is essential for patients to follow their healthcare provider’s recommendations regarding dosage, administration, and monitoring to ensure optimal outcomes and minimize potential risks. As with any medication, ongoing communication with healthcare professionals is vital for managing diabetes effectively.